International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all regions and industry verticals to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
Global Autoimmune Disease Diagnosis Market Research Report 2022-2027:
According to the latest report by IMARC Group, titled " AutoimmuneDiseaseDiagnosisMarket:GlobalIndustryTrends,Share,Size,Growth,Opportunitya ndForecast2022-2027
," the global autoimmune disease diagnosis market size reached US$ 3.5 Billion in 2021.
An autoimmune disease refers to a medical condition that results from an abnormal immune response to a normally functioning body part. The immune system is unable to distinguish between healthy tissues and potentially harmful antigens in this condition. As a result, it releases proteins called autoantibodies to attack the healthy cells that destroy the functioning cells, tissues, and organs of the body. At present, more than 80 types of autoimmune disorders have been identified by scientists that include type I diabetes, psoriasis, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. The diagnosis of these diseases requires a combination of physical examination, antinuclear antibody test (ANA), C-reactive protein (CRP), tissue biopsy and X-rays in order to determine the nature and severity of the condition.
Request for a PDF sample of this report: https://www.imarcgroup.com/autoimmune-disease-diagnosis-market/requestsample
The global market is primarily driven by the growing prevalence of numerous autoimmune disorders, along with the increasing demand for precise and efficient diagnostic solutions. This has led to the adoption of advanced technologies to conduct multiple tests simultaneously with faster and accurate results. These technologies are also focused on providing an improved diagnosis with higher sensitivity, which is providing an impetus to the market growth. In addition to this, there has been a rising preference for laboratory automation. This, along with the increasing healthcare expenditure, is acting as a major growth-inducing factor. Moreover, numerous government and non-government organizations (NGOs) are undertaking initiatives to spread awareness regarding the diagnosis and treatment of autoimmune disorders. Several research and diagnostics institutes are also investing in programs that aim to develop improved diagnostic methods and novel therapeutic solutions for these medical disorders, which, in turn, is expected to create a positive outlook for the market. Looking forward, IMARC Group expects the market is expected to grow at a CAGR of 6.4% during 2022-2027.
View Report TOC, Figures and Tables:
https://www.imarcgroup.com/autoimmune-disease-diagnosis-market
Key Market Segmentation
The research report includes the following segments:
Breakup by Product Type:
• Consumables and Assay Kits
• Instruments
Breakup by Disease Type:
• Systemic Autoimmune Disease
• Rheumatoid Arthritis
• Psoriasis
• Systemic Lupus Erythematosus (SLE)
• Multiple Sclerosis
• Others
• Localized Autoimmune Disease
• Inflammatory Bowel Disease
• Type 1 Diabetes
• Thyroid
• Others
Breakup by Test Type:
• Routine Laboratory Tests
• Inflammatory Markers
• Autoantibodies and Immunologic Tests
• Others
Breakup by End-User:
• Clinical Laboratories
• Hospitals
• Others
Breakup by Region:
• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa
Competitive Landscape with Key Players:
• Abbott Laboratories
• AESKU.GROUP
• Danaher Corp
• bioMérieux SA
• Bio-Rad Laboratories, Inc
• PerkinElmer Inc
• Hemagen Diagnostics, Inc
• Inova Diagnostics, Inc
• Myriad Genetics, Inc
• Quest Diagnostics Incorporated
• Siemens Healthineers AG
• SQI Diagnostics
• Thermo Fisher Scientific Inc
• Trinity Biotech plc
1. Whatisthesizeoftheglobalautoimmunediseasediagnosismarket?
2. WhathasbeentheimpactofCOVID-19ontheglobalautoimmunediseasediagnosismarket?
3. Whatistheexpectedgrowthrateoftheglobalautoimmunediseasediagnosismarket?
4. Whatarethekeyfactorsdrivingtheglobalautoimmunediseasediagnosismarket?
5. Whatisthebreakupoftheglobalautoimmunediseasediagnosismarketbasedontheproduct type?
6. Whatisthebreakupoftheglobalautoimmunediseasediagnosismarketbasedonthedisease type?
7. Whatisthebreakupoftheglobalautoimmunediseasediagnosismarketbasedonthetesttype?
8. Whatarethekeyregionsintheglobalautoimmunediseasediagnosismarket?
9. Whoarethekeyplayers/companiesintheglobalautoimmunediseasediagnosismarket?
7.1.2.2
7.1.2.3
7.1.2.4
7.1.2.5
7.1.3
Clickheretovisitthecompletetableofcontentwithlistoffiguresandtables: https://www.imarcgroup.com/autoimmune-disease-diagnosis-market/toc
We are the trusted business partners to the world's leading corporates, governments, and institutions
We are the trusted business partners to the world's leading corporates, governments, and institutions
© 2022 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.
